Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
- Dolomite Centre
- Unit 1, Anglian Business Park
- Orchard Rd.
- Royston , SG8 5TW
- UNITED KINGDOM
Dolomite has its roots in Syrris, which was founded in 2001 by Mark Gilligan and Richard Gray to address the challenges faced by the pharmaceutical industry. While Syrris focuses on flow chemistry and microreactors, Dolomite was set up as a subsidiary to provide microfluidic solutions to customers around the world in a very wide range of applications outside the field of research chemistry.